cjc1295 and ipamorelin peptide CJC 1295 7.5mg & 15mg CJC-1295 and Ipamorelin Peptide Injection

Specifically, Ipamorelin was observed to elevate growth hormone concentrations up to approximately 80 milli-international units per liter (mIU/l), which is about 26.6 nanograms per milliliter (ng/ml)

Sermorelin body composition changes: Measurable shifts in lean muscle mass and body fat percentage generally appear between eight and twelve weeks

CJC-1295/Ipamorelin side effects are generally limited to injection site reactions, mild water retention, and transient headaches

According to NCBI reports of breathing discomfort and increased risk of bronchospasm in such cases

Individuals with a history of cancer, diabetes, or cardiovascular disease should exercise caution when using Tesamorelin or CJC-1295, as both peptides can increase IGF-1 levels, which may exacerbate these conditions

Some people may also experience impairments in thinking, judgment, and motor coordination